Genetic Mechanisms of TP53 Loss of Heterozygosity in Barrett's Esophagus: Implications for Biomarker Validation
Open Access
- 1 March 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (3) , 509-516
- https://doi.org/10.1158/1055-9965.epi-05-0246
Abstract
Background and Aims: 17p (TP53) loss of heterozygosity (LOH) has been reported to be predictive of progression from Barrett's esophagus to esophageal adenocarcinoma, but the mechanism by which TP53 LOH develops is unknown. It could be (a) DNA deletion, (b) LOH without copy number change, or (c) tetraploidy followed by genetic loss. If an alternative biomarker assay, such as fluorescence in situ hybridization (FISH), provided equivalent results, then translation to the clinic might be accelerated, because LOH genotyping is presently limited to research centers.Keywords
This publication has 67 references indexed in Scilit:
- Biomarkers of Esophageal Adenocarcinoma and Barrett’s EsophagusCancer Research, 2004
- Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagusGut, 2003
- International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in barrett's esophagus (BE): Results of 24-month follow-upGastroenterology, 2003
- Loss of Heterozygosity Associated with Uniparental Disomy in Breast CarcinomaLaboratory Investigation, 2002
- Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinomaBritish Journal of Surgery, 2002
- Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomasGenes, Chromosomes and Cancer, 2001
- Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction RegionThe American Journal of Pathology, 1998
- Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.Gut, 1996
- The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequenceSurgical Oncology, 1995
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989